The high dose of Wegovy is one part of Novo Nordisk's plan to defend its obesity business, along with a major ...

Danish pharmaceutical giant Novo Nordisk has announced a new 800-million-yuan (approximately USD 111.9 million) investment to ...

Under the agreement, the two institutions will co-develop programmes across three key areas: health system capacity building, ...

The miner's shares rallied Tuesday after President Trump said he would impose 50% duties on copper imports, [sending prices for the metal soaring]( ...

By Sanchayaita Roy and Sukriti Gupta (Reuters) -European shares rose on Wednesday, led by banks, as investors awaited signs ...

Novo Nordisk is a global diabetes and weight loss leader with strong long-term growth prospects. Read why NVO stock is a ...

Analysts said the deal with Novo was likely giving Hims “‘credibility’ or increased consumer traffic,” adding that the ...

Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging ...

SEOUL, SOUTH KOREA - Media OutReach Newswire - 9 July 2025 - Health2Sync, Asia's leading digital chronic disease management platform, announced the successful integration of Smart Cap Mallya® for ...

Novo Nordisk A/S (NYSE:NVO) is one of the 11 Best Foreign Stocks to Buy According to Hedge Funds. On June 18, TD Cowen ...

Novo Nordisk submits a higher 7.2 mg dose of Wegovy for EMA approval, backed by trials showing 21% weight loss in obesity and ...

The demand for obesity drugs in India is surging as Eli Lilly and Novo Nordisk compete. A Pakistani startup sends prosthetics ...